Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients

Effect of EGFR amplification on the prognosis of EGFR-mutated advanced non–small-cell lung cancer patients: A prospective observational study

10 p | 3 | 2

Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer

7 p | 13 | 2

Epidermal growth factor receptor gene mutations in patients with lung adenocarcinoma differ by frequency and type between Uighur and Han ethnic groups in Xinjiang Autonomous Region

5 p | 4 | 1

Prognostic analysis of patients with nonsmall cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

10 p | 11 | 1

Pneumatosis intestinalis induced by osimertinib in a patient with lung adenocarcinoma harbouring epidermal growth factor receptor gene mutation with simultaneously detected exon 19 deletion and T790 M point mutation: A case report

7 p | 10 | 1

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand

12 p | 14 | 1

Activity of EGFR-tyrosine kinase and ALK inhibitors for EML4–ALK-rearranged non–small–cell lung cancer harbored coexisting EGFR mutation

5 p | 10 | 0

Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non–small-cell lung cancer

7 p | 11 | 0

High frequency of epidermal growth factor receptor mutations in non - small cell lung cancers in Vietnam

12 p | 21 | 0